Company Filing History:
Years Active: 2008-2014
Title: Roxana Schlam: Innovator in Pharmaceutical Chemistry
Introduction
Roxana Schlam is a prominent inventor based in East Brunswick, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative crystalline forms of various compounds.
Latest Patents
Roxana Schlam holds 2 patents that showcase her expertise. Her latest patents include crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide. This invention provides pharmaceutical compositions that are crucial in the treatment of cancer and other proliferative diseases. Additionally, she has developed crystalline forms of a factor Xa inhibitor, which includes processes for production and methods for treating thromboembolic disorders.
Career Highlights
Roxana Schlam is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Throughout her career, Roxana has collaborated with notable colleagues, including Michael J. Orwat and Mary F. Malley. These partnerships have further enhanced her contributions to the field.
Conclusion
Roxana Schlam's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of various diseases. Her patents reflect her dedication to improving healthcare through scientific innovation.